Updated:
Ellington Healthcare Partners
Ellington Healthcare Partners is an early-stage venture capital firm headquartered in Marlton, United States. The firm applies scientific expertise in...
Overview
Ellington Healthcare Partners is an early-stage venture capital firm headquartered in Marlton, United States. The firm applies scientific expertise in regenerative medicine, stem cell biology, immunology, and nanotechnology to identify disease-treatment opportunities. Its investment strategy centers on backing early-stage companies developing therapeutic innovations. Ellington Healthcare Partners leverages domain-specific knowledge to evaluate breakthroughs emerging from advanced biomedical research fields. The firm targets opportunities aligned with disease treatment and related technological advancements. No additional details regarding portfolio companies, fund size, or later-stage activity are specified in the available facts.
General information
Firm type
Venture Capital
Location
Country
United States
City
Marlton
Corporate office
Marlton, United States
Sector focus
Frequently asked questions
What is Ellington Healthcare Partners?
Ellington Healthcare Partners is an early-stage venture capital firm headquartered in Marlton, United States, that focuses on identifying disease-treatment opportunities.
What scientific expertise does the firm apply to its investments?
The firm applies expertise in regenerative medicine, stem cell biology, immunology, and nanotechnology to identify disease-treatment opportunities.
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: